2017
DOI: 10.3389/fmicb.2017.01394
|View full text |Cite
|
Sign up to set email alerts
|

Heterologous Prime-Boost Vaccination Enhances TsPmy’s Protective Immunity against Trichinella spiralis Infection in a Murine Model

Abstract: TsPmy is a paramyosin expressed by parasitic Trichinella spiralis and confers a protective immunity when its recombinant protein or DNA was used as an immunogen. To improve its immunogenicity and vaccine efficacy, we conducted a heterologous prime-boost strategy by orally delivering one dose of TsPmy DNA carried by attenuated Salmonella typhimurium (SL7207), followed by two doses of recombinant TsPmy intramuscularly. This strategy effectively induced intestinal mucosal sIgA response and an enhanced and balance… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
7
0

Year Published

2018
2018
2022
2022

Publication Types

Select...
8
1

Relationship

2
7

Authors

Journals

citations
Cited by 11 publications
(8 citation statements)
references
References 32 publications
1
7
0
Order By: Relevance
“…Vaccinated mice exhibited a 54% reduction in adult worm burden of intestines at day 5 after challenge and a 33% reduction in larval burden of muscles at day 35 post infection. The larval and adult burden reduction observed in our study is similar to those from previous studies (Cui et al 2013, Long et al 2014, Wang et al 2017b. Our results were also consistent with previous reports which indicated that Th2-predominant immune responses in vaccinated mice have been shown to be important, of which anti-Trichinella antibodies play an important role in immune protection against infection with T. spiralis (see Wang et al 2013b, Long et al 2014.…”
Section: A B D C E Fsupporting
confidence: 93%
“…Vaccinated mice exhibited a 54% reduction in adult worm burden of intestines at day 5 after challenge and a 33% reduction in larval burden of muscles at day 35 post infection. The larval and adult burden reduction observed in our study is similar to those from previous studies (Cui et al 2013, Long et al 2014, Wang et al 2017b. Our results were also consistent with previous reports which indicated that Th2-predominant immune responses in vaccinated mice have been shown to be important, of which anti-Trichinella antibodies play an important role in immune protection against infection with T. spiralis (see Wang et al 2013b, Long et al 2014.…”
Section: A B D C E Fsupporting
confidence: 93%
“…Therefore, in order to improve vaccination efficacy, the Trichinella common antigens in ES products and worm surface antigens from different worm stages are required to be used for development of anti- Trichinella vaccine, and the multivalent vaccines against various T. spiralis stages (especially the early IIL and NBL stages) should be explored [ 9 ]. Moreover, other vaccination strategies including the heterologous prime-boost immunization, genetic adjuvants or codon optimization, and different vaccination routes should also be developed [ 69 ]. For example, intranasal vaccination of mice with attenuated Salmonella expressing a T. spiralis gp43 antigen-derived 30-mer peptide fused with adjuvant C3d-P28 has achieved a 92.8% intestinal adult reduction following challenge infection [ 14 ].…”
Section: Discussionmentioning
confidence: 99%
“…The monoclonal antibody, 9G3, which targets the complement binding site of Ts-Pmy, could partially block its complement inhibitory activity, thereby increasing complement-mediated killing of larvae ( Hao et al, 2014 ). Mice immunized with recombinant protein ( Yang et al, 2010 ), epitope peptides ( Wei et al, 2011 ; Gu et al, 2013 , 2017 ), or the DNA ( Wang et al, 2016 , 2017 ) of Ts-Pmy were conferred with significant protection against the challenge of T. spiralis muscle larvae. Thus, Ts-Pmy has become the leading vaccine candidate for the control of trichinellosis.…”
Section: Parasite-generated Complement Regulatory Proteins As Vaccinementioning
confidence: 99%